Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL, Doré BT, Momparler LF. Momparler RL, et al. Among authors: dore bt. Cancer Lett. 1990 Oct 8;54(1-2):21-8. doi: 10.1016/0304-3835(90)90086-d. Cancer Lett. 1990. PMID: 1698532
Effect of 5-aza-2'-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells.
Doré BT, Chomienne C, Momparler RL. Doré BT, et al. Cancer Chemother Pharmacol. 1998;41(4):275-80. doi: 10.1007/s002800050740. Cancer Chemother Pharmacol. 1998. PMID: 9488596
Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs.
Doré BT, Momparler RL. Doré BT, et al. Leuk Res. 1996 Sep;20(9):761-9. doi: 10.1016/0145-2126(96)00043-4. Leuk Res. 1996. PMID: 8947586
Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells.
Doré BT, Uskokovìc MR, Momparler RL. Doré BT, et al. Leuk Res. 1993 Sep;17(9):749-57. doi: 10.1016/0145-2126(93)90108-w. Leuk Res. 1993. PMID: 8396695
Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase.
Momparler RL, Doré BT, Labiberté J, Momparler LF. Momparler RL, et al. Among authors: dore bt. Leukemia. 1993 May;7 Suppl 1:17-20. Leukemia. 1993. PMID: 7683351
Increased sensitivity to a vitamin D3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid.
Doré BT, Uskokovic MR, Momparler RL. Doré BT, et al. Leukemia. 1994 Dec;8(12):2179-82. Leukemia. 1994. PMID: 7528858
Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells.
Doré BT, Momparler RL. Doré BT, et al. Anticancer Drugs. 1992 Jun;3(3):281-7. doi: 10.1097/00001813-199206000-00012. Anticancer Drugs. 1992. PMID: 1381972
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.
Liang MH, Simard JF, Costenbader K, Dore BT, Ward M, Fortin PR, Illei GG, Manzi S, Mittleman B, Buyon J, Gupta S, Abrahamowicz M. Liang MH, et al. Among authors: dore bt. Endocr Metab Immune Disord Drug Targets. 2009 Mar;9(1):108-12. doi: 10.2174/187153009787582388. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19275685 Free PMC article.
Feedback